BUZZ-U.S. STOCKS ON THE MOVE-Oil, solar stocks, FXCM, Akebia
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were little changed in volatile trading on Monday, two days ahead of an expected U.S. interest rate hike, as crude oil prices hovered near 11-year lows. The Dow Jones industrial average was up 0.28 percent at 17,313.85, the S&P 500 was up 0.11 percent at 2,014.57 and the Nasdaq Composite was down 0.13 percent at 4,927.119.
** GOPRO INC, $16.16, -15.61 pct
Citigroup cut its rating on the wearable camera maker's stock to "neutral" from "buy" on Friday. It also slashed its price target to $22 from $75. Citigroup analysts said they had thought GoPro would recover from poor sales of Hero 4 Session but now think demand for GoPro products is softening.
Morgan Stanley also cut its rating to "underweight" from "equal-weight".
** NEPHROGENEX INC, $2.43, +68.75 pct
The drug developer says the U.S. FDA allows human testing of its experimental drug to treat acute kidney injury. The drug is designed to reduce kidney injury, post-injury tissue scarring and improve kidney function recovery.